7.28
price down icon3.45%   -0.26
after-market Dopo l'orario di chiusura: 7.31 0.03 +0.41%
loading

Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie

pulisher
Sep 10, 2026

Bank of New York Mellon Corp Buys Shares of 218,126 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 10, 2026
pulisher
Sep 09, 2026

Wellington Management Group LLP Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 09, 2026
pulisher
Sep 07, 2026

Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 07, 2026
pulisher
Sep 05, 2026

Achieve Life Sciences Stock Price Forecast. Should You Buy ACHV? - StockInvest.us

Sep 05, 2026
pulisher
Sep 03, 2026

Achieve Life Sciences Grants Equity Awards to 7 New Employees Under 2024 Inducement Plan - Quiver Quantitative

Sep 03, 2026
pulisher
Sep 03, 2026

Press Release: Achieve Life Sciences Announced Granting of New Hire Inducement Awards - Moomoo

Sep 03, 2026
pulisher
Sep 03, 2026

Achieve Life Sciences (NASDAQ:ACHV) Sets New 1-Year HighHere's What Happened - MarketBeat

Sep 03, 2026
pulisher
Sep 02, 2026

BlackRock Inc. Invests $34.43 Million in Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 02, 2026
pulisher
Sep 01, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 5.2%Time to Buy? - MarketBeat

Sep 01, 2026
pulisher
Sep 01, 2026

Alyeska Investment Group L.P. Acquires Shares of 1,925,722 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Sep 01, 2026
pulisher
Aug 30, 2026

Jupiter Topco LLC Acquires Shares of 2,751,032 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Aug 30, 2026
pulisher
Aug 28, 2026

Achieve Life Sciences Inc. (ACHV) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 28, 2026

Spruce Street Capital LP Purchases Shares of 736,637 Achieve Life Sciences, Inc. $ACHV - MarketBeat

Aug 28, 2026
pulisher
Aug 27, 2026

Achieve Life Sciences Inc. (ACHV) Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 27, 2026
pulisher
Aug 27, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Aug 27, 2026
pulisher
Aug 24, 2026

This Insider Has Just Sold Shares In Achieve Life Sciences - simplywall.st

Aug 24, 2026
pulisher
Aug 21, 2026

Insider Selling: Achieve Life Sciences (NASDAQ:ACHV) Director Sells $175,114.74 in Stock - MarketBeat

Aug 21, 2026
pulisher
Aug 21, 2026

Achieve Life (NASDAQ: ACHV) director keeps 208,249 shares after sale - Stock Titan

Aug 21, 2026
pulisher
Aug 19, 2026

Achieve Life (NASDAQ: ACHV) director to sell 20,626 shares - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Achieve Life Sciences (NASDAQ:ACHV) Sets New 12-Month HighShould You Buy? - MarketBeat

Aug 19, 2026
pulisher
Aug 17, 2026

Achieve Life Sciences (ACHV) draws new passive holder near 10% - Stock Titan

Aug 17, 2026
pulisher
Aug 17, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 17, 2026
pulisher
Aug 16, 2026

Achieve Life Sciences Inc (ACHV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aug 16, 2026
pulisher
Aug 15, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Achieve Life SciencesEnters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock - TradingView

Aug 14, 2026
pulisher
Aug 14, 2026

Achieve Life Sciences (ACHV) launches $150M at-the-market stock program - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV): When Will It Breakeven? - Moomoo

Aug 14, 2026
pulisher
Aug 14, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - simplywall.st

Aug 14, 2026
pulisher
Aug 14, 2026

(08/14/26) ACHV: A Speculative Trade in the Biotech Sector - moneyshow.com

Aug 14, 2026
pulisher
Aug 13, 2026

ACHV Q1 2026 Earnings: Smaller-Than-Expected Loss Lifts Shares 8.37%Long-Term Guidance - vinanet.vn

Aug 13, 2026
pulisher
Aug 13, 2026

Janus Henderson Group (ACHV) reports 5,502,064 Achieve Life shares under management - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Aug 13, 2026
pulisher
Aug 13, 2026

Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

Achieve Life Sciences, Inc. Stock 12‑Month Price Target Cut to $13.83, Implies 107% Upside - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Achieve Life Sciences (NASDAQ:ACHV) Hits New 12-Month HighHere's Why - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

Achieve stock gains Overweight at Morgan Stanley (ACHV:NASDAQ) - Seeking Alpha

Aug 13, 2026
pulisher
Aug 13, 2026

HC Wainwright Has Optimistic Outlook of ACHV Q3 Earnings - MarketBeat

Aug 13, 2026
pulisher
Aug 13, 2026

ACHV Initiates Coverage On by Morgan Stanley -- Rating Set to Ov - GuruFocus

Aug 13, 2026
pulisher
Aug 13, 2026

Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit. - webull.com

Aug 13, 2026
pulisher
Aug 13, 2026

Morgan Stanley initiates Achieve Life Sciences stock at overweight By Investing.com - Investing.com Nigeria

Aug 13, 2026
pulisher
Aug 13, 2026

Morgan Stanley initiates Achieve Life Sciences stock at overweight - Investing.com

Aug 13, 2026
pulisher
Aug 12, 2026

H.C. Wainwright reiterates Achieve Life Sciences stock rating at buy By Investing.com - Investing.com Canada

Aug 12, 2026
pulisher
Aug 12, 2026

Research Analysts Set Expectations for ACHV FY2028 Earnings - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences Submits Q2 2026 Form 10-Q Highlighting NDA Resubmission and Financial Risks - Kalkine Media

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences Releases Q2 2026 Financial Results - AlphaStreet

Aug 11, 2026
pulisher
Aug 11, 2026

ACHIEVE LIFE SCIENCES, INC. 6M 2026: Net loss $(84.9)M, EPS $(1.15) — 10-Q Summary - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences (ACHV) swings to larger $84.9M loss on warrant costs - stocktitan.net

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financing - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

FDA declines to approve Achieve smoking cessation drug; Q4 resubmission planned - scanx.trade

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences Q2 Results: EPS misses estimate, losses widen - scanx.trade

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences (NASDAQ:ACHV) Posts Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences (ACHV) Advances Cytisinicline Commercializ - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Achieve Life Sciences (ACHV) - The Globe and Mail

Aug 10, 2026
pulisher
Aug 10, 2026

ACHV Edges Higher to $6.67 as Achieve Life Sciences Consolidates Between Support and ResistanceMFI Oversold - vinanet.vn

Aug 10, 2026
pulisher
Aug 07, 2026

Achieve Life Sciences Inc (ACHV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 05, 2026

ACHV Q2'26 Earnings: EPS estimate is (0.16) USD - TradingView

Aug 05, 2026
pulisher
Aug 04, 2026

Achieve Life Sciences (ACHV) Holds Gains at $6.39 as Biotech Momentum BuildsMarket Leader Picks - vinanet.vn

Aug 04, 2026
pulisher
Aug 03, 2026

Achieve Life Sciences Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView

Aug 03, 2026
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):